Results 151 to 160 of about 19,553 (185)

Single-molecule validation and optimised protocols for the use of secondary nanobodies in multiplexed immunoassays. [PDF]

J Microsc
Saleeb R, O'Shaughnessy J, Ferguson R, Adams CT, Horrocks MH.   +4 more
europepmc   +1 more source

Dynamic Binder Exchange Improves Protein Labeling Efficiency in DNA-PAINT up to 15-Fold. [PDF]

Angew Chem Int Ed Engl
Steinek C, Pachmayr I, Strauss S, Honsa M, Kwon J, Jungmann R.   +5 more
europepmc   +1 more source

US28 nanobodies

, 2020
openaire   +1 more source

A Unified Dataset for Antibody and Nanobody Design Including Sequence, Structure, and Binding Affinity Data. [PDF]

Sci Data
Wu Y, Liu X, Hrovatin K, Wu D, Linker S, Winkel M, Tan F.   +6 more
europepmc   +1 more source

Noncanonical amino acid-aided synthesis of anti-PD-L1 bispecific nanobody for colon cancer immunotherapy. [PDF]

Commun Biol
Hu X, Jiang L, Yuan H, Chen W, Guo Y, Gao M, Song Y, Wang Z, Wang Y, Zhang M, de Marco A, Huang H, Kang G, Yu H.   +13 more
europepmc   +1 more source

Ancient and Emerging Nanostructures for Innovations to Fight Head and Neck Cancer. [PDF]

Cells
Kummer N, Acet Ö, Acet BÖ, Blueggel M, Khamis A, Gül D, Knauer SK, Stauber RH.   +7 more
europepmc   +1 more source

DNA Nanostructure-Templated Multivalency Enables Broad-Spectrum Virus Inhibition. [PDF]

Adv Sci (Weinh)
Umrao S, Dwivedy A, Gandavadi D, Chen C, Zhou L, Duan J, Mareddy V, Fang Y, Wang X.   +8 more
europepmc   +1 more source

A high-affinity CEA-targeted nanobody for ⁶⁸Ga PET imaging and ¹⁷⁷Lu-based radioisotope therapy: preclinical and first-in-human evaluation. [PDF]

J Nanobiotechnology
Zhang L, Zhou M, Lu C, Zhao P, Shi N, Zhou Y, Yao C, Yang X, Tian J, Wang J, Ma Y, Huang Q, Xu C, Gao P, Zhou W, Hu S, Luo L.   +16 more
europepmc   +1 more source